Filing Details

Accession Number:
0001628280-21-001281
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-02 15:22:50
Reporting Period:
2021-01-29
Accepted Time:
2021-02-02 15:22:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600620 Aurinia Pharmaceuticals Inc. AUPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1837374 Jill Leversage #1203-4464 Markham Street
Victoria A1 V8Z7X8
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2021-01-29 400 $16.03 400 No 4 P Indirect By spouse
Common Stock Acquisiton 2021-01-29 1,200 $16.03 1,200 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By spouse
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 1,000 Indirect By Shelburne Wood Protection
Footnotes
  1. Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the purchase date.
  2. The shares were inadvertently reported as direct by the reporting person in the previously filed Form 3.